Clinical Research

Clinical studies represent the all-important interface between innovative research and successful implementation in the clinic. The findings from clinical studies determine the further development of therapies and the future status of health care provision. In this respect, the studies carried out at the Schüchtermann-Klinik provide our patients with direct access to the latest therapeutic developments and offer them the opportunity to benefit from the latest research results.

The spectrum comprises almost all areas of modern cardiovascular medicine. In accordance with the qualification of the Schüchtermann-Klinik as a supraregional cardiac insufficiency centre, the therapy of advanced cardiac insufficiency represents a special focus of research. The research focus is pursued by all disciplines at the clinic, from diagnostics to rehabilitation.

Besides basic research projects and technical or sports science research projects, the Schüchtermann-Klinik Bad Rothenfelde also participates in numerous clinical studies an register studies:

Clinical studies:

• ENCOURAGE-AF (Phase III / since 2020, ongoing)
• NOAH-AFNET 6 (Phase III / since 2019, ongoing)
• TIARA II (Phase II / since 2019, ongoing)
• TRILUMINATE (Phase II / since 2018, ongoing)
• CEASE-AF (Phase III / since 2016, ongoing)
• BIO-Continue (Phase III / since 2015, ongoing)
• MORE MPP (Phase III / since 2014, ongoing)

Register studies:

• GERAADA-Register (since 2020, ongoing)
• SCAD-Register (since 2019, ongoing)
• BIO-Stream-Register (since 2019, ongoing)
• CASE-Register (since 2017, ongoing)
• SOURCE3-Register (since 2014, ongoing)
• Internal-TAVI-Register (since 2008, ongoing)
• Internal-Ablation-Register (since 2003, ongoing)